Independent Sponsor-Side Assessment

Independent oversight for sponsors who can't afford to find out late.

ClariTria provides independent sponsor-side clinical operations assessment — helping sponsors understand what the available study information is actually saying about enrollment, site performance, CRO execution, timelines and operational risk.

Built for U.S. sponsors — with additional on-the-ground capability in Serbia and Bulgaria for sponsors expanding into Eastern Europe.

Keep your CRO. Add an independent view.

What ClariTria Is

Your CRO runs the study. ClariTria independently evaluates the picture.

ClariTria does not manage your CRO. It independently evaluates the information your CRO and sites generate.

You get a second, independent read on what's actually happening — not a replacement for your CRO's reporting, but a check on it.

Keep your CRO. Add an independent view.

How ClariTria Fits

An independent branch, not a layer inside the CRO relationship.

Role 01

Sponsor

Owns
The program, the budget and the decisions
Contracts
The CRO, to deliver the study
Engages
ClariTria, separately and independently
Reports to
Final decision-making authority

Why Sponsors Use ClariTria

Why sponsors use independent assessment.

We're not positioned against your CRO — we sit alongside them, on your side of the table.

That means findings you can act on before a routine status update becomes a missed milestone.

See the Full Comparison →

The Problem

More reporting doesn't always mean better visibility.

Sponsors receive CRO status reports, enrollment reports, site reports, monitoring reports, data reports, risk logs, action trackers and timeline updates. The question is: does the information being reported tell the whole story?

  • Enrollment looks acceptable.
    → But 60% comes from two sites.
  • Sites are “active.”
    → But several haven't enrolled a patient in weeks.
  • Corrective actions are “open.”
    → But deadlines keep moving.
  • The CRO reports “on track.”
    → But the milestone keeps slipping.

ClariTria provides an independent assessment of the operational picture — so the sponsor has another informed perspective when making decisions.

What ClariTria Reports

We look beyond the headline status.

ClariTria turns fragmented operational information into an independent sponsor-level view of study performance, emerging risk and areas requiring attention — see what we review, what you receive, and a sample of what the reporting actually looks like.

See a Sample Report →

What We Do

Four ways we support sponsors.

Complex studies, multi-study engagements and specialized projects are scoped individually — these are the core ways sponsors typically work with us.

01 · Oversight

Independent CRO & Study Oversight

Ongoing assessment of study health, CRO execution, site performance and emerging operational risk.

Best for: Sponsors who want continuous independent visibility.

Learn more →

02 · Intelligence

Study Health & Performance Assessment

A focused assessment of an existing clinical program to identify operational strengths, weaknesses and emerging risks.

Best for: Sponsors who need an independent picture of where the study stands today.

03 · Intervention

Recruitment & Site Recovery

Independent assessment of recruitment problems, site performance and potential corrective actions.

Best for: Sponsors facing slowing enrollment or underperforming sites.

Learn more →

04 · Representation

Independent Clinical Operations Support

Additional clinical-operations expertise for sponsors that need experienced support without building a large internal team.

Best for: Emerging and virtual biotech companies.

Who We Help

Built for sponsors who need experienced eyes without building another department.

Emerging Biotech

You're advancing a clinical program without a large internal clinical-operations organization.

Virtual Biotech

Your operations are outsourced, but you still need independent visibility and experienced oversight.

Small & Mid-Size Pharma

You have internal expertise but want an independent assessment of CRO execution and study performance.

Expanding Into New Regions

You need local clinical-operations knowledge without immediately building a local infrastructure.

You probably need ClariTria when…

  • Your CRO says the study is on track, but you're not convinced.
  • Enrollment is slowing.
  • A small number of sites are carrying the study.
  • Too many sites are underperforming.
  • CRO reports don't provide enough clarity.
  • Study milestones keep moving.
  • Corrective actions repeatedly miss deadlines.
  • You don't have enough internal clinical operations leadership.
  • You're entering a new region.
  • You need an independent assessment before making a major study decision.

How It Works

From study information to independent insight.

  1. 01

    Review

    We review available study information, reporting and operational signals.

  2. 02

    Assess

    We independently evaluate patterns, trends, inconsistencies and areas of potential risk.

  3. 03

    Interpret

    We determine what appears meaningful from a sponsor-level perspective.

  4. 04

    Report

    We communicate findings directly to the sponsor in a clear, concise format.

  5. 05

    Monitor

    For ongoing engagements, we track how the operational picture changes over time.

Case Studies

Selected engagements.

CRO Status Reports

“It’s a slow time of year for recruitment — sites are busy with other clinical work.”

ClariTria Review Identified

  • Feasibility and Site Qualification Visits completed on schedule, but zero subjects enrolled after several weeks of active recruitment
  • Monitoring visit and call reports were templated and did not account for the lack of enrollment
  • A separate sponsor had recently opened a similar study at the same sites, with a larger per-patient budget and broader eligibility criteria
  • Sites had been directing available candidates to the competing study — a fact absent from all CRO reporting

Outcome

With the actual cause identified, the sponsor could act directly — raising site budget and priority in the negotiation — instead of continuing to wait on a seasonal explanation that was never the real story.

Anonymized ClariTria engagement — identifying details altered to protect sponsor and site confidentiality.

Additional anonymized case studies are available upon request during an initial conversation.

See What We Found

About

Experienced clinical operations leadership — without the overhead of another CRO.

The founder is part of the product. ClariTria's assessment is built on direct, hands-on clinical operations experience — not a bench of junior staff.

Portrait of Dr. Aleksandar Petrov

Dr. Aleksandar Petrov

Founder & CEO

15+ years in clinical research ~1,000 monitoring visits conducted 40+ clinical trials Senior CRA / Lead CRA experience Sponsor, CRO & site-level experience U.S. + Eastern European experience

Recognized for combining a strong medical background, operational excellence, extensive international experience, regulatory expertise, and hands-on problem-solving to deliver complex clinical research programs.

Supported by a network of experienced clinical operations contractors across the U.S. and Eastern Europe as engagements require.

Therapeutic Experience

CNS / Psychiatry Cardiovascular Dental Dermatology Endocrinology / Metabolism Gastroenterology Infectious Disease Nephrology Neurology Oncology Respiratory
linkedin.com/company/claritria →

Eastern Europe

Expanding into Eastern Europe?

Local clinical-operations knowledge without building a local team.

ClariTria provides additional operational support and regional insight for sponsors evaluating or conducting clinical research in Serbia and Bulgaria.

See Serbia & Bulgaria in Detail →

Pricing

Ongoing Sponsor Oversight

Packages start at $3,600/month, plus one-time engagements for feasibility, live study oversight, rescue & recovery, and Eastern Europe market entry.

See Full Pricing →

Not Sure Where Your Study Is Actually Stuck?

Tell us what you're seeing.

We'll help determine whether the issue is enrollment, sites, CRO reporting, data, timelines or operations.

Get an Independent Study Assessment

No obligation. Initial discussion focused on understanding the study and the problem.